Standout Papers

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms 2002 2026 2010 2018 1.5k
  1. CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms (2005)
    Richard V. Parry, Jens M. Chemnitz et al. Molecular and Cellular Biology
  2. The CD28 Signaling Pathway Regulates Glucose Metabolism (2002)
    Kenneth A. Frauwirth, James L. Riley et al. Immunity
  3. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation (2004)
    Jens M. Chemnitz, Richard V. Parry et al. The Journal of Immunology
  4. Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo (2009)
    Michael C. Milone, Jonathan D. Fish et al. Molecular Therapy
  5. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains (2009)
    Carmine Carpenito, Michael C. Milone et al. Proceedings of the National Academy of Sciences
  6. PD‐1 signaling in primary T cells (2009)
    James L. Riley Immunological Reviews
  7. Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation (2002)
    Edward Y. Woo, Heidi Yeh et al. The Journal of Immunology
  8. Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells (2012)
    John Scholler, Troy Brady et al. Science Translational Medicine

Immediate Impact

33 by Nobel laureates 39 from Science/Nature 314 standout
Sub-graph 1 of 10

Citing Papers

Co-opting signalling molecules enables logic-gated control of CAR T cells
2023 StandoutNature
CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
214 intermediate papers

Works of James L. Riley being referenced

Genetic engineering of T cells for immunotherapy
2021
CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
2019
and 54 more

Author Peers

Author Last Decade Papers Cites
James L. Riley 12183 9451 1254 3984 146 18.4k
Crystal L. Mackall 8317 6851 869 3141 167 15.7k
Philip D. Greenberg 15068 11265 1301 4407 240 22.2k
Kai W. Wucherpfennig 14285 6788 348 6271 203 23.3k
Luca Gattinoni 10689 10252 289 4036 101 15.8k
Karolina Palucka 14400 4765 497 4689 124 18.7k
Esteban Celis 13292 8443 629 5298 205 18.4k
Susan M. Kaech 19417 5867 1103 4529 122 24.4k
Pedro Romero 19634 9622 445 8478 338 26.2k
Peter Van Endert 8336 3618 623 4529 171 13.4k
Douglas T. Fearon 15069 6526 351 5351 177 24.1k

All Works

Loading papers...

Rankless by CCL
2026